Gentamicin: A great way to start

Australian Prescriber

Volumn 33, Issue 5, 2010, Pages 134-135

  Moulds, Robert F W ^a   Jeyasingham, Melanie S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; GENTAMICIN; METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; BACTERIAL ENDOCARDITIS; BRUCELLOSIS; CLOSTRIDIUM DIFFICILE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EAR DISEASE; EDITORIAL; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEARING IMPAIRMENT; HUMAN; KIDNEY DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NOMOGRAM; PATIENT MONITORING; PRACTICE GUIDELINE; PSEUDOMONAS INFECTION; RISK FACTOR; STREPTOCOCCUS INFECTION; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 78049282983     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2010.062     Document Type: Editorial

References (9)

1. Turnidge J. Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin North Am 2003;17:503-28.
2. Bertino JS Jr, Booker LA, Franck PA, Jenkins PL, Franck KR, Nafziger AN. Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring. J Infect Dis 1993;167:173-9.
3. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995;39:650-5.
4. Drusano GL, Ambrose PG, Bhavnani SM, Bertino JS, Nafziger AN, Louie A. Back to the future: using aminoglycosides again and how to dose them optimally. Clin Infect Dis 2007;45:753-60.
5. Aldeyab MA, Monnet DL, Lopez-Lozano JM, Hughes CM, Scott MG, Kearney MP, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008;62:593-600.
6. Tokars JI, Satake S, Rimland D, Carson L, Miller ER, Killum E, et al. The prevalence of colonization with vancomycinresistant Enterococcus at a Veterans' Affairs institution. Infect Control Hosp Epidemiol 1999;20:171-5.
7. Lopez-Lozano JM, Monnet DL, Yague A, Burgos A, Gonzalo N, Campillos P, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 2000;14:21-31.
8. Thomas C, Stevenson M, Riley TV. Antibiotics and hospitalacquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003;51:1339-50.
9. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Version 14. Melbourne: Therapeutic Guidelines Limited; 2010.